Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for synthesizing imidazole-amino acid derivative and related compound

A technology of azole compounds and alkylating agents, applied in the field of 2-substituted azole derivatives and new intermediate compounds

Inactive Publication Date: 2012-07-11
JANSSEN PHARMA NV
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, they did not apply their method to generate β-hydroxyamino acids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing imidazole-amino acid derivative and related compound
  • Method for synthesizing imidazole-amino acid derivative and related compound
  • Method for synthesizing imidazole-amino acid derivative and related compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0301]

[0302]A solution of commercially available N-tritylserine methyl ester (15.0 g, 41.5 mmol) in 350 mL of toluene was stirred with triethylamine (16 mL, 115 mmol) until the solids dissolved. A solution of phosgene (20% (w / w) in toluene, 25 ml, 47.2 mmol) was then added and the solution was stirred for 2 hours. The mixture was then poured into 100 ml 1N HCl and the layers were separated. After adding 40ml of 3N NaOH to the aqueous layer, it was extracted twice with 100ml of 1:1 toluene:dichloromethane. The combined organic layers were then washed once with 100 ml 1N HCl, twice with 100 ml 1N NaOH and once with 100 ml brine. The resulting solution was dried over sodium sulfate and passed through a pad of silica gel (0.5", 500ml sintered glass funnel). The silica gel was washed with 250ml ethyl acetate and concentrated in vacuo to give a crude foam (16.5g, >100%).

[0303] The solid prepared above was dissolved in 300 ml dry THF and cooled to an internal temperature o...

Embodiment 2

[0306]

[0307] Compound 1 (450 mg, 1.25 mmol) and 1-benzylimidazole (159 mg, 1.0 mmol) were dissolved in 5 ml of acetonitrile. Then N,N-dimethylcarbamoyl chloride (0.125ml, 1.35mmol) and N,N-diisopropylethylamine (0.53ml, 3.0mmol) were added. After stirring for 3 days, the solution was poured into 10 ml of water and 20 ml of dichloromethane. The layers were separated and the aqueous layer was extracted with an additional 10 mL of dichloromethane. The combined organic extracts were washed successively with 20 ml of 1N sodium hydroxide and 20 ml of brine, dried over sodium sulfate, and purified by silica gel column chromatography (10% ethyl acetate and hexane mixture to 75% ethyl acetate). Compound 2 was isolated (420 mg, 72% yield, off-white foam).

[0308] HRMS: 587.2662 (MH + The calculated value is 587.2658).

Embodiment 3

[0310]

[0311] Compound 2 (600 mg, 1.02 mmol) was dissolved in 1% water in trifluoroacetic acid and stirred at ambient temperature until cleavage of the trityl group was complete. After the solution was concentrated in vacuo, the crude intermediate was dissolved in 18 ml of 2:1 ethanol:water. Solid potassium hydroxide (2.0 g, 30 mmol) was added and the solution was heated to reflux for 18 hours. The intermediate was extracted by acidifying the solution with concentrated hydrochloric acid, partitioned between 30ml ether and 20ml water. The layers were separated, and after the organic layer was extracted with 20 ml of 1N hydrochloric acid, the combined aqueous extracts were neutralized with solid sodium bicarbonate. 1,4-2 After alkane (25ml) was added to the aqueous solution, potassium hydroxide (560mg, 8.5mmol) and di-tert-butyl dicarbonate (0.3ml, 1.3mmol) were added. The solution was stirred at ambient temperature for 1 hour, then heated to reflux for 20 minutes, cool...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for synthesizing an imidazole-amino acid derivative and a related compound, and relates to a method for synthesizing a 2-substituted azole compound shown as a formula (I), the compound shown as the formula (I) and an intermediate compound in the synthesis method.

Description

[0001] This application is an application for an invention patent with the application number 200580051217.4 (international application number PCT / US2005 / 023048), the application date being June 29, 2005, and the invention title being "Synthetic method of imidazole-amino acid derivatives and related compounds". Divisional application. [0002] Cross References to Related Applications [0003] No application applicable. [0004] Statement Regarding Federally Funded Research and Development [0005] Research and development of the inventions described below is not a federally funded program. Background of the invention [0006] Amino acids containing 1,3-azoles have utility as analogs of natural amino acids for incorporation into biologically active molecules. In particular, they are building blocks of many bioactive peptides and are useful in the preparation of antimicrobial agents. Currently, there is no general synthetic method for them. [0007] Saeed and Young describe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D233/64C07D263/24C07D277/20C07D407/04C07D413/06A61K31/4164A61K31/4172A61K31/421A61K31/422A61P31/00
Inventor D·J·赫拉斯塔C·A·奇菲查克
Owner JANSSEN PHARMA NV